Chengdu Zenitar Biomedical Technology Co., Ltd

This first-in-human study tested a new drug called Purinostat Mesylate (PM) in 29 adults with advanced blood cancers that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see how the drug moves through the body. Early lab stud…

This early-stage study tested a new oral drug called flonoltinib in adults with myeloproliferative neoplasms (MPNs), a group of rare bone marrow cancers. The main goals were to check the drug's safety, find the highest tolerable dose, and see how the body processes it. Researcher…

This was a first-in-human study to check the safety and side effects of a new experimental pill called ZL-82. The trial involved 41 healthy volunteers who took either the drug or a placebo. Researchers measured how the drug moved through the body and checked for any effects on he…

This early-stage study aimed to understand if eating a high-fat meal changes how the body absorbs and processes a single dose of a new drug called flonoltinib. It involved 24 healthy volunteers who took the pill both on an empty stomach and after a meal. The main goal was to meas…

This was a first-in-human study to check the safety and how the body processes a new drug called flonoltinib maleate. It involved 40 healthy adult volunteers in China who received either a single dose of the drug or a placebo. The main goal was to see how safe the drug was and to…